Reply to Jin
et al
.: Inhaled Treprostinil after Initial Clinical Worsening: To Continue or Not to Continue, That's the Question
Am J Respir Crit Care Med
.
2022 May 15;205(10):1251-1252.
doi: 10.1164/rccm.202201-0081LE.
Author
Steven D Nathan
1
Affiliation
1
Inova Fairfax Hospital Falls Church, Virginia.
PMID:
35353003
PMCID:
PMC9872812
DOI:
10.1164/rccm.202201-0081LE
No abstract available
Publication types
Letter
Comment
MeSH terms
Antihypertensive Agents* / therapeutic use
Epoprostenol* / analogs & derivatives
Epoprostenol* / therapeutic use
Humans
Substances
Antihypertensive Agents
Epoprostenol
treprostinil